News Center-Livzon Pharmaceutical Group Inc.

News Center

New Lijuzhu Magazine

In 2019, the list of the top 100 pharmaceutical companies in China was released, and Chairman Zhu Baoguo participated in the roundtable forum.

In 2019, the list of the top 100 pharmaceutical companies in China was released, and Chairman Zhu Baoguo participated in the roundtable forum.

2020-09-02

LIZHU Group released the 2019 Environmental, Social and Governance Report

LIZHU Group released the 2019 Environmental, Social and Governance Report

Since the national launch of a new round of healthcare system reform in 2019, our country has gradually established a comprehensive basic medical security system over the past decade, with various key health indicators for residents generally better than the average level of middle and high-income countries. In 2019, the revised "Prohibition of Certain Goods Management Law of the People's Republic of China" was passed, and the State Council's medical reform deepening group released "Several Policy Measures for Further Deepening the Reform of the Medical and Health System," marking that the new medical reform is entering the "fast lane" and is "restarting" towards the goal of universal health coverage.

2020-04-15

LIZHU Group 2019 Annual Report

LIZHU Group 2019 Annual Report

2020-04-14

Lizhu Pharmaceutical's wholly-owned subsidiary leads the Series B financing of Jiangsu New Element.

Lizhu Pharmaceutical's wholly-owned subsidiary leads the Series B financing of Jiangsu New Element.

2020-03-11

Lijuzhu Group included in the Hang Seng Sustainable Development Corporate Benchmark Index

Lijuzhu Group included in the Hang Seng Sustainable Development Corporate Benchmark Index

Lijun Group has been included in the Hang Seng A-Share Sustainable Development Enterprises Benchmark Index, which recognizes Lijun Group's commitment to sustainable development and reflects its outstanding performance in the areas of business development, environment, society, and corporate governance. Lijun will continue to innovate and strive for progress, bringing the best returns to society and investors through excellent business performance, contributing to a healthy China.

2019-08-20

A picture to understand the 2019 half-year report of Livzon Pharmaceutical Group

A picture to understand the 2019 half-year report of Livzon Pharmaceutical Group

In the first half of 2019, Livzon's operating income was 4.939 billion yuan, a year-on-year increase of 8.20%; net profit was 835 million yuan, a year-on-year increase of 23.50%; net profit attributable to the parent company was 739 million yuan, a year-on-year increase of 16.67%; net profit attributable to the parent company after deducting non-recurring gains and losses was 659 million yuan, a year-on-year increase of 15.32%.

2019-08-17

Hou Xuemei: Focused on innovative drug research for thirty-two years, benefiting millions of patients.

Hou Xuemei: Focused on innovative drug research for thirty-two years, benefiting millions of patients.

From the special topic: Guangdong News Broadcast   Guangdong Satellite TV News Broadcast "Patriotic Feelings and Strivers" series report: Hou Xuemei is the chief scientist of Livzon Pharmaceutical Group Research Institute. She has focused on research and development for 32 years in her scientific research position, leading the team to develop a new drug for the digestive field, Esomeprazole, which has become a milestone in the history of new drug development in China.    Let's turn the clock back to 2001. At that time, 70% of domestic gastrointestinal medications were proton pump inhibitors, and the four drugs on the market were all monopolized by foreign large enterprises, making the Price very expensive. Hou Xuemei made up her mind that to break the monopoly, she had to carve out a bloody path and create her own innovative drug.   Livzon Pharmaceutical Group Research Institute Chief Scientist.

2019-04-12

Great! The Secretary of the Shaoguan Municipal Committee provides services on-site.

Great! The Secretary of the Shaoguan Municipal Committee provides services on-site.

On the afternoon of February 26, Li Hongjun, Secretary of the Shaoguan Municipal Committee of the Communist Party of China and Director of the Shaoguan Municipal People's Congress Standing Committee, visited the Livzon Pharmaceutical Group for inspection and research, conducting on-site work. Accompanying Secretary Li Hongjun were Shaoguan's Vice Mayor Chen Lei, Director of the Municipal Bureau of Industry and Information Technology Chen Laian, and Director of the Shaoguan Market Supervision Administration Ou Xinquan, among others.   President Tang Yanggang of Livzon Group warmly welcomed Secretary Li Hongjun's visit for inspection and research. President Tang first introduced the History of Livzon Group and the nine advantageous areas that Livzon aims to strengthen and expand in the future to Secretary Li and his team.  Then, both the government and enterprises engaged in candid and effective discussions on issues of mutual concern.

2019-02-27

< 1...9 10 11...25 > proceed page

Address: No.38, Chuangye North Road, Jinwan District, Zhuhai, Guangdong, P.R.China

京ICP备10002622号

Website :www.300.cn SEO [ Privacy Policy ]

Internet Drug Information Service Qualification Certificate: Guangdong-Non-Operating -2020-0186

Drug Business License: Guangdong AA7560155

Business License

Home | E-mail | Legal Statement

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.